BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23618357)

  • 1. Down-regulation of GRIM-19 is associated with STAT3 overexpression in breast carcinomas.
    Zhou T; Chao L; Rong G; Wang C; Ma R; Wang X
    Hum Pathol; 2013 Sep; 44(9):1773-9. PubMed ID: 23618357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma.
    Li F; Ren W; Zhao Y; Fu Z; Ji Y; Zhu Y; Qin C
    Med Oncol; 2012 Dec; 29(5):3046-54. PubMed ID: 22492280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin synergistically increases effects of β-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3-dependent and STAT3-independent pathways.
    Ren M; Wang Y; Wu X; Ge S; Wang B
    J Drug Target; 2017 Mar; 25(3):247-254. PubMed ID: 27677346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].
    Gong LB; Luo XL; Liu SY; Tao DD; Gong JP; Hu JB
    Ai Zheng; 2007 Jul; 26(7):683-7. PubMed ID: 17626740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of GRIM-19 inhibits the growth and invasion of human breast cancer cells.
    Zhang W; Du Y; Jiang T; Geng W; Yuan J; Zhang D
    Mol Med Rep; 2015 Aug; 12(2):2919-25. PubMed ID: 25955394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.
    Yue X; Zhao P; Wu K; Huang J; Zhang W; Wu Y; Liang X; He X
    Tumour Biol; 2016 Jul; 37(7):9789-96. PubMed ID: 26810068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
    Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
    Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.
    Zhou Y; Li M; Wei Y; Feng D; Peng C; Weng H; Ma Y; Bao L; Nallar S; Kalakonda S; Xiao W; Kalvakolanu DV; Ling B
    J Interferon Cytokine Res; 2009 Oct; 29(10):695-703. PubMed ID: 19642906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a gene associated with retinoid-interferon-induced mortality 19 (GRIM-19) on STAT3-induced gene expression in renal carcinoma.
    Cui L; Meng Q; Wen J; Yan Z; Gao Z; Tian Y; Xu P; Lian P; Yu H
    J Biochem; 2018 Oct; 164(4):285-294. PubMed ID: 29961871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
    Nallar SC; Kalakonda S; Lindner DJ; Lorenz RR; Lamarre E; Weihua X; Kalvakolanu DV
    J Biol Chem; 2013 Mar; 288(11):7930-7941. PubMed ID: 23386605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell Culture.
    Li YG; Han BB; Li F; Yu JW; Dong ZF; Niu GM; Qing YW; Li JB; Wei M; Zhu W
    PLoS One; 2016; 11(4):e0153659. PubMed ID: 27101310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.
    Zhang J; Chu D; Kawamura T; Tanaka K; He S
    J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling.
    Kong D; Chen J; Sun X; Lin Y; Du Y; Huang D; Cheng H; He P; Yang L; Wu S; Zhao L; Meng X
    Biosci Trends; 2019; 13(4):342-350. PubMed ID: 31527330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
    Liu C; Zhou S; Ke CS; Li NP; Wu RL
    Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.
    Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC
    Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRIM-19 in Health and Disease.
    Máximo V; Lima J; Soares P; Silva A; Bento I; Sobrinho-Simões M
    Adv Anat Pathol; 2008 Jan; 15(1):46-53. PubMed ID: 18156812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo.
    Wang T; Yan XB; Zhao JJ; Ye J; Jiang ZF; Wu DR; Xiao WH; Liu RY
    Lung Cancer; 2011 Jun; 72(3):287-93. PubMed ID: 21040996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
    Kalakonda S; Nallar SC; Gong P; Lindner DJ; Goldblum SE; Reddy SP; Kalvakolanu DV
    Am J Pathol; 2007 Oct; 171(4):1352-68. PubMed ID: 17823279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
    Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
    Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.